Drug intelligence / Profile preview

WS204

Development stage
Unknown
Lead developer
University of Leeds
Modality
Small Molecules
01

Overview

WS204 is a potent and selective small molecule antagonist of the Transient Receptor Potential Canonical 4 (TRPC4) channel. Identified through high-throughput screening, it exhibits high selectivity for TRPC4 over other members of the TRPC family, including TRPC1, TRPC3, TRPC5, and TRPC6, as well as other TRP channels such as TRPV1 and TRPM8. By blocking TRPC4-mediated calcium entry, WS204 serves as a critical pharmacological tool for investigating the physiological and pathological roles of TRPC4 in various tissues, including smooth muscle contraction, neurotransmission, and vascular function. While primarily used as a research reagent, TRPC4 inhibition has been explored preclinically for potential therapeutic applications in treating anxiety, depression, and certain cardiovascular conditions.

Other names
4-methyl-2-(1-piperidinyl)-quinoline
02

Targets

TRPC4 (Transient receptor potential cation channel subfamily C member 4)TRPC5 (Transient receptor potential Canonical-5)TRPC3

Beyond the preview

Go deeper on WS204.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on WS204.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call